Latest Series C+ Funding Rounds
Later-stage rounds, from Series C onwards, for companies expanding products, distribution and operations.
- Rounds
- 420 All time
- Disclosed funding
- $108.3B 379 disclosed amounts
- Median round
- $120M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| Q QuadricCompany profile Quadric is a licensor of fully programmable general-purpose AI inference processor IP Quadric is a licensor of fully programmable general-purpose AI inference processor IP | $30M | Series CSeries C+ | AI | United States | Investors | |
| A AlpacaCompany profile Brokerage APIs and custody infrastructure that let financial businesses embed investing and trading into their own products. Brokerage APIs and custody infrastructure that let financial businesses embed investing and trading into their own products. | $150M | Series DSeries C+ | Fintech | United States | Investors | |
| O AI-powered platform for military command and operations | $200M | Series DSeries C+ | Defense tech | United States | Investors | |
| N NucleraCompany profile Provides rapid access to functional proteins through benchtop eProtein Discovery System Provides rapid access to functional proteins through benchtop eProtein Discovery System | $12M | Series C+ | Biotech | United Kingdom | Investors | |
| D DeepgramCompany profile Deepgram provides real-time voice APIs for speech recognition, speech synthesis and voice AI applications. Deepgram provides real-time voice APIs for speech recognition, speech synthesis and voice AI applications. | $130M | Series CSeries C+ | AI | United States | Investors | |
| OT Oricell TherapeuticsCompany profile Develops next-generation cell therapies for oncology and immunology Develops next-generation cell therapies for oncology and immunology | $70M | Series C1Series C+ | Biotech | China | Investors | |
| IM Inquis MedicalCompany profile Develops mechanical thrombectomy systems for venous thromboembolic disease Develops mechanical thrombectomy systems for venous thromboembolic disease | $75M | Series CSeries C+ | Healthtech | United States | Investors Undisclosed | |
| T TorqCompany profile Empowers enterprises to instantly and precisely detect and respond to security events at scale Empowers enterprises to instantly and precisely detect and respond to security events at scale | $140M | Series DSeries C+ | Cybersecurity | United States | Investors | |
| R Provides enterprise-grade infrastructure for stablecoin-powered payments | $250M | Series CSeries C+ | Fintech | United States | Investors | |
| b bit.bioCompany profile Creates functional, human-relevant cells and models for research, drug discovery, and development Creates functional, human-relevant cells and models for research, drug discovery, and development | $50M | Series CSeries C+ | Biotech | United Kingdom | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Andreessen Horowitz (a16z)
Labelbox, Valon, Devoted Health
35rounds3led - 2Sequoia Capital
Blacksmith, Abby Care, Instinct
31rounds2led - 3Lightspeed
Enveda, Snorkel AI, Profound
28rounds3led - 4General Catalyst
Legora, Modal Labs, Varda
27rounds0led - 5Y Combinator (YC)
Blacksmith, Jeeves, Hubble Network
21rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.